These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


688 related items for PubMed ID: 18314357

  • 41. Increased presence of stromal myofibroblasts and tenascin-C with malignant progression in canine mammary tumors.
    Yoshimura H, Michishita M, Ohkusu-Tsukada K, Takahashi K.
    Vet Pathol; 2011 Jan; 48(1):313-21. PubMed ID: 20571146
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
    Sorenmo KU, Kristiansen VM, Cofone MA, Shofer FS, Breen AM, Langeland M, Mongil CM, Grondahl AM, Teige J, Goldschmidt MH.
    Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: a multivariate study.
    De Matos AJ, Lopes CC, Faustino AM, Carvalheira JG, Dos Santos MS, Rutteman GR, Gärtner Mde F.
    Anticancer Res; 2006 Sep; 26(3A):1821-6. PubMed ID: 16827113
    [Abstract] [Full Text] [Related]

  • 48. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue--an immunohistochemical study.
    Dias Pereira P, Carvalheira J, Gärtner F.
    Vet J; 2004 Sep; 168(2):180-5. PubMed ID: 15301767
    [Abstract] [Full Text] [Related]

  • 49. RAD51 protein expression is increased in canine mammary carcinomas.
    Klopfleisch R, Schütze M, Gruber AD.
    Vet Pathol; 2010 Jan; 47(1):98-101. PubMed ID: 20080488
    [Abstract] [Full Text] [Related]

  • 50. TSLC1 tumour-suppressor gene expression in canine mast cell tumours.
    Taylor F, Murphy S, Hoather T, Dobson J, Scase T.
    Vet Comp Oncol; 2010 Dec; 8(4):263-72. PubMed ID: 21062408
    [Abstract] [Full Text] [Related]

  • 51. BRCA1 and p53 protein expression in cultured ovarian surface epithelial cells derived from women with and without a BRCA1 germline mutation.
    Piek JM, Dorsman JC, Massuger LF, Ansink AC, Weegenaar J, Shvarts A, Kenemans P, Verheijen RH.
    Arch Gynecol Obstet; 2006 Oct; 274(6):327-31. PubMed ID: 16826413
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
    Lavalle GE, Bertagnolli AC, Tavares WL, Cassali GD.
    Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Lymphocyte infiltration, expression of interleukin (IL) -1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours.
    Kim JH, Yu CH, Yhee JY, Im KS, Sur JH.
    J Comp Pathol; 2010 Nov; 142(2-3):177-86. PubMed ID: 19959182
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 35.